Clinical Trial Update: A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for TQC2938 Injection in healthy adult subjects evaluating safety, with asthma listed as the condition of interest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TQC2938 Injection (TQC2938)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Asthma | Phase 1 | Status: UNKNOWN